Recent News

• 05.31.2026 - Immunocore presents updated Phase 1 data of brenetafusp in patients with heavily pretreated advanced melanoma
• 05.06.2026 - Immunocore reports first quarter financial results and provides a business update
• 04.19.2026 - KIMMTRAK doubles the likelihood of being alive at five years for first line HLA-A*02:01+ patients with metastatic uveal melanoma

Recent Filings

• 05.28.2026 - 4 Statement of changes in beneficial ownership of securities
• 05.28.2026 - 4 Statement of changes in beneficial ownership of securities
• 05.28.2026 - 4 Statement of changes in beneficial ownership of securities
• 05.28.2026 - 4 Statement of changes in beneficial ownership of securities
• 05.28.2026 - 4 Statement of changes in beneficial ownership of securities
• 05.28.2026 - 4 Statement of changes in beneficial ownership of securities
• 05.27.2026 - 8-K Current report
• 05.22.2026 - 144 Report of proposed sale of securities
• 05.21.2026 - 144 Report of proposed sale of securities
• 05.15.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors